NVRO Nevro Medical: Likuiditas cepet

The price action history of Nevro Corp. (NVRO) demonstrates the current coefficient 0.00. Nevro Corp. (NVRO) develops advanced neurostimulators, optimizing component logistics to maintain high profitability. The firm generates revenue through the sale of chronic pain management systems and specialized software. Management is currently conducting a cost restructuring to protect the margins of its core medtech segment amid stagnant market demand.

Nevro Medical (NVRO) - Likuiditas darurat saka 04.07.2022 nganti 13.04.2025

nevro.com - rincian analitis lan metrik utama (NVRO)

- rega saham lan prakiraan rega para ahli:

Rega saham Nevro Corporation|NVRO - Prakiraan konsensus analis

- data kapitalisasi saham perusahaan:

Nilai pasar Nevro Corporation|NVRO - Nilai Wutuh Bisnis

- data kapitalisasi buku:

Nilai Buku saben Saham Nevro|NVRO - Ekuitas Perusahaan|Rasio Kapitalisasi marang Aset Bersih nevro.com|NVRO - Total Aset Perusahaan

- statistik kawajiban utang lan likuiditas:

Rasio Total Utang marang Ekuitas Nevro Corp.|NVRO - Rasio silihan jangka dawa marang modal|Utang jangka cendhak marang modal Nevro|NVRO - Gunggung kewajiban utang perusahaan|Utang-utang marang kapitalisasi buku Nevro Corporation|NVRO - Kewajiban jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Nevro|Likuiditas cepet nevro.com

- indikator bathi lan kelipatan valuasi:

NVRO - Penghasilan resik

Analisis kabeh metrik perusahaan:Nevro Corporation - NVRO

Nevro Corp. (NVRO) partnerships with leading US medical centers require stable funding for operational processes. By analyzing the ratio of highly liquid assets to short-term liabilities, investors assess the company's ability to instantaneously settle debts without liquidating stimulator inventories. This metric considers only cash and accounts receivable, highlighting risks of a "hard cash" shortage. This conservative approach to liquidity is characteristic of a Growth-segment asset.

Pesaing utama